Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities

Renal cell carcinoma (RCC) is among the most lethal urological malignancies once metastatic. The introduction of immune checkpoint inhibitors has revolutionized the therapeutic landscape of metastatic RCC, nevertheless, a significant proportion of patients will experience disease progression. Novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohl, Laura, Friedhoff, Jana, Jurcic, Christina, Teroerde, Miriam, Schindler, Isabella, Strepi, Konstantina, Schneider, Felix, Kaczorowski, Adam, Hohenfellner, Markus, Duensing, Anette, Duensing, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128013/
https://www.ncbi.nlm.nih.gov/pubmed/35619925
http://dx.doi.org/10.3389/fonc.2022.889686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128013/
https://www.ncbi.nlm.nih.gov/pubmed/35619925
http://dx.doi.org/10.3389/fonc.2022.889686

Ejemplares similares